切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2021, Vol. 11 ›› Issue (01) : 28 -30. doi: 10.3877/cma.j.issn.2095-2015.2021.01.006

所属专题: 文献

全民健康助力全面小康专栏

提高克罗恩病早诊早治水平改善疗效和预后
葛文松1,()   
  1. 1. 200092 上海交通大学医学院附属新华医院消化内科
  • 收稿日期:2020-10-05 出版日期:2021-02-01
  • 通信作者: 葛文松

By improving the level of early diagnosis and treatment of Crohn disease in order to improve the curative effect and prognosis

Wensong Ge1,()   

  1. 1. Department of Gastroenterology, Shanghai Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
  • Received:2020-10-05 Published:2021-02-01
  • Corresponding author: Wensong Ge
  • About author:
    Corresponding author: Ge Wensong, Email:
引用本文:

葛文松. 提高克罗恩病早诊早治水平改善疗效和预后[J/OL]. 中华消化病与影像杂志(电子版), 2021, 11(01): 28-30.

Wensong Ge. By improving the level of early diagnosis and treatment of Crohn disease in order to improve the curative effect and prognosis[J/OL]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2021, 11(01): 28-30.

克罗恩病的早诊早治是一个复杂而有挑战的临床问题。克罗恩病的早诊早治对于疗改善效和预后,促进疾病缓解、减少并发症、预防复发、提高生活质量都有非常重要意义。结合临床表现、内镜、病理、实验室、影像等资料综合判断是早期诊断的重要手段,早期积极治疗力争黏膜愈合是改善克罗恩病疗效和预后的重要途径。

The early diagnosis and treatment of Crohn disease is a complex and challenging clinical problem.Early diagnosis and treatment of Crohn disease is of great significance for improving therapeutic effect and prognosis, promoting disease remission, reducing complications, preventing recurrence and improving quality of life.Comprehensive judgment based on clinical manifestations, endoscopy, pathology, laboratory, imaging and other data is an important means of early diagnosis, and treatment in early stage to strive for mucosal healing is an important way to improve the efficacy and prognosis of Crohn disease.

1
Peyrin-Biroulet L, Loftus EV Jr, Colombel JF,et al.Early Crohn disease:a proposed definition for use in diseasemodification trials[J].Gut,2010,59(2): 141-147.
2
Peyrin-Biroulet L, Billioud V, D′Haens G,et al.Development of the Paris definition of early Crohn′s disease for disease modification trials:results of an international expert opinionprocess[J].Am J Gastroenterol,2012,107(12): 1770-1776.
3
Schoepfer AM, Dehlavi MA, Fournier N,et al.IBD Cohort Study Group.Diagnostic delay in Crohn′s disease is associated with a complicated disease course and increased operation rate[J].Am J Gastroenterol,2013,108(11): 1744-1753.
4
Baert F, Moortgat L, van Assche G,et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn′s disease[J]. Gastroenterology,2010,138(2): 463-468.
5
Colombel JF, Rutgeerts PJ, Sandborn WJ,et al. Adalimumab induces deep remission in patients with Crohn′s disease[J]. Clin Gastroenterol Hepatol,2014,12(3): 414-422.e5.
6
Colombel JF, Rutgeerts P, Reinisch W,et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis[J]. Gastroenterology,2011,141(4): 1194-1201.
7
Darr U, Khan N. Treat to target in inflammatory bowel disease:an updated review of literature[J]. Curr Treat Options Gastroenterol,2017,15(1): 116-125.
8
Peyrin-Biroulet L, Reinisch W, Jean-Frederic Colombel et al.Clinical disease activity,C-reactive protein normalisation and mucosal healing in Crohn′s disease in the SONIC trial[J].Gut,2014,63(1): 88-95.
9
Sandborn WJ, Panaccione R, Thakkar R,et al. Duration of Crohn′s disease affects mucosal healing in adalimumab-treated patients:results from EXTEND[J]. J Crohns Colitis Suppl,2010,4: S36-S37.
10
Engel T, Ungar B, Yung DE,et al.Vedolizumab in IBD-Lessons From Real-world Experience;A Systematic Review and Pooled Analysis[J].J Crohn Colitis,2018,12: 245-257.
11
Henderson P, Anderson NH, Wilson DC.The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease:a systematic review and meta-analysis[J].Am J Gastroenterol,2014,109(5): 637-645.
12
Aomatsu T, Imaeda H, Matsumoto K,et al.Faecal chitinase 3-like-1:a novel biomarker of disease activity in paediatric inflammatory bowel disease[J].Aliment Pharmacol Ther,2011,34(8): 941-948.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[3] 易柏成, 李旭光, 王容容, 王新璇. 数字化3D打印导板应用于上前牙钙化根管治疗2例[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 385-390.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[6] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[7] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[8] 石海波, 赵旭东, 王聪, 曲巍. 气肿性肾盂肾炎、气肿性膀胱炎并脓毒性休克一例报道并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 644-647.
[9] 王秋生. 胆道良性疾病诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 779-782.
[10] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[11] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[12] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[15] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?